Canaccord noted Sharecare initaited a strategic review in August 2022 which has yielded a propsed merger offer from Claritas Capital for a proposed range of $1.35-$1.80 per share which is below the firm’s targt of $3.00. Canacord said despite the offer below their target price, they are encouraged that there is interest in the long-term opportunity of Sharecare’s businesses and they note management has not responded to the offer as of yet.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on SHCR:
- Sharecare confirms receipt of unsolicited proposal from Claritas Capital
- Sharecare to report third quarter fiscal 2023 financial results on Thursday, November 9
- Sharecare core business worth ‘far more’ than Claritas proposal, says BTIG
- Sharecare jumps after Claritas forwards $1.35-$1.80 per share takeover bid
- Winners of Sharecare Awards revealed live at HLTH on Monday, Oct. 9